According to Matthew Kuruc, COO of PIN member ProFact Proteomics, the network aims to help smaller firms offer complete solutions similar to those increasingly provided by large instrument vendors and to popularize non-mass spec-based proteomics workflows.
With executives from Agilent, Thermo Fisher, Waters, and Danaher presenting this week at the JP Morgan Healthcare Conference, UPLC as well as triple quadrupole and qual-quan mass spec proved primary areas of discussion.
The release of a long-awaited protein biomarker test, increased adoption of a major instrument platform, and a pair of proteome mapping milestones marked a year in which several much-anticipated advances in proteomics arrived.
The purchase, which is expected to close in the first quarter of 2011, will add a range of ion and liquid chromatography products to Thermo Fisher's portfolio, including platforms aimed at proteomics research like Dionex's UltiMate 3000 RSLCnano LC system.
Since launching its Accela HPLC line in 2006, Thermo Fisher has been largely quiet on the LC front, but according to a company official, today's acquisition "allows us to offer a more tightly integrated solution for proteomic LC/MS applications.”